13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
10:20 am Invited Talk: Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease @ Sathyam Hall
Invited Talk: Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease @ Sathyam Hall
Aug 13 @ 10:20 am – 10:40 am
Invited Talk:  Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease @ Sathyam Hall | Vallikavu | Kerala | India
Rajgopal Srinivasan, Ph.D. Principal Scientist & Head Bio IT R&D, TCS Innovation Labs, India Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease Genome sequencing technologies are generating an abundance of data on human genetic variations. A big challenge
11:50 am Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Aug 13 @ 11:50 am – 12:12 pm
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall | Vallikavu | Kerala | India
V. Nagaraja Ph.D. Professor, Indian Institute of Science, Bengaluru, India Perturbation of DNA topology in mycobacteria To maintain the topological homeostasis of the genome in the cell, DNA topoisomerases catalyse DNA cleavage, strand passage and rejoining of the ends. Thus,
7:03 pm Delegate Talk: A proteomic approach to decipher the mechanism of action and molecular targets of curcumin in Bacillus subtilis @ Acharya Hall
Delegate Talk: A proteomic approach to decipher the mechanism of action and molecular targets of curcumin in Bacillus subtilis @ Acharya Hall
Aug 13 @ 7:03 pm – 7:13 pm
Delegate Talk: A proteomic approach to decipher the mechanism of action and molecular targets of curcumin in Bacillus subtilis @ Acharya Hall | Vallikavu | Kerala | India
Jaipal Panga Reddy, Dulal Panda and Sanjeeva Srivastava The rapid emergence of microbial resistance against the ever increasing number of infectious diseases has been a major hurdle in hunt for novel antibiotics and inventive targets required to combat these dreaded